Smart-Money SignalDistribution · 42/100— Insiders are net sellers over 90 days (-$10.9M, 48 sales vs 28 buys)
Revenue$246.1M
Net Income-$92.5M
EPS$-0.56
Market Cap$11.2B
Price Performance
Historical data including institutional events
Company Profile
B
Brett P. Monia
CEO & Executive Director
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.
